gm dL

Related by string. gm dl * GMs . GMD . GMS . gms . Gm . GMED . GM : GM Brian Cashman . GM Omar Minaya . Pass Yards Gm . Rush Yards Gm . genetically modified GM . Total Yards Gm . GM Billy Beane . GM Jay Feaster / DLD . DLs . DLS . Dl . ding ling . dl . Ding Ling . dling : Yard Freestyle =-#.# mg dL . DL Ravindra Reddy . ng dL . DL Myron Pryor . dl #H . -#.# mg dL [002] . -#.# mg dL [001] . DL Calarco Funeral Home * *

Related by context. Frequent words. (Click for all words.) 62 μg L 61 μmol L 60 μg kg 60 % CI #.#-#.# [003] 60 hemoglobin concentration 59 P = .# 59 CI -#.# 59 serum concentrations 59 g dl 58 serum albumin 58 mEq L 58 pg ml 58 serum uric acid 57 g dL 57 ventilatory 57 % CI #.#-#.# [007] 57 mmol l 57 p = .# [002] 57 CK MB 56 mL kg 56 statistically significant p = 56 ml min 56 ng dL 56 HbA 1c 56 ketorolac 56 lispro 56 #mg/day [001] 55 Cmax 55 platelet reactivity 55 glomerular filtration rate 55 HBsAg 55 pg mL 55 XIENCE V demonstrated 55 Pulse CO Oximeter 55 confidence interval #.#-#.# 55 HbA1C 54 alkaline phosphatase 54 prospectively defined 54 poor metabolizers 54 Hb 54 prespecified 54 serum calcium 54 clinically meaningful improvement 54 beta blocker therapy 54 erythrocyte sedimentation rate 54 OGTT 54 nonobese 54 Thrombolysis 54 Secondary endpoints include 54 Secondary endpoints included 54 fluvastatin 53 Hb levels 53 53 diastolic BP 53 HSCT 53 rhGH 53 serum sodium 53 postop 53 epithelial ovarian cancer 53 LVEF 53 infarct size 53 Exclusion criteria 53 creatinine levels 53 thromboprophylaxis 53 creatine kinase 53 serum glucose 53 achieved statistical significance 52 nmol L 52 noninferiority 52 D dimer 52 ng mL 52 hsCRP 52 murine model 52 serum phosphorus 52 creatinine clearance 52 mg kg dose 52 hypoxemia 52 antibody titers 52 left ventricular systolic 52 % CI #.#-#.# [006] 52 #:#-# [033] 52 apolipoprotein B 52 glycemia 52 glycated hemoglobin 52 carotid stenosis 52 thyroid stimulating hormone 52 serum PSA 51 platelet inhibition 51 eplerenone 51 apoB 51 nM 51 lymph node metastasis 51 irbesartan 51 hs CRP 51 coadministration 51 pharmacokinetic parameters 51 nondiabetic 51 QTc 51 dobutamine 51 mcg dose 51 CD4 + cell

Back to home page